Literature DB >> 22460232

The relationship between high-density lipoprotein cholesterol and coronary collateral circulation in patients with coronary artery disease.

Hasan Kadi1, Huseyin Ozyurt, Koksal Ceyhan, Fatih Koc, Atac Celik, Turgay Burucu.   

Abstract

INTRODUCTION: High-density lipoprotein cholesterol (HDL-C) promotes cholesterol efflux from macrophage foam cells in atheroma plaques. In addition, HDL-C has anti-inflammatory and endothelium-protective properties. Despite that the only prerequisite for collateral development is shown to be the degree of coronary artery stenosis, there are significant differences even among patients with a similar degree of coronary artery disease.
OBJECTIVE: We designed this study to investigate a possible association between HDL-C and coronary collateral circulation (CCC).
MATERIALS AND METHODS: All study participants had at least one occluded major coronary artery. Demographic, clinical, and laboratory data were obtained from patients' medical records. To classify CCC, we used Rentrop classification. The patients were then classified as having poor CCC (Rentrop grades 0-1) or good CCC (Rentrop grades 2-3). We performed t test and the χ test in comparing groups and multivariate logistics regression analysis to determine the predictors of CCC. The study population consisted of 151 patients (mean age, 63.7 ± 9 years; 76.2% male).
RESULTS: Forty-nine patients had poor CCC and 102 patients had good CCC. The proportion of previous myocardial infarctions, serum triglycerides, and low HDL-C levels were more frequent in the poor CCC group (P = 0.026, P = 0.015, and P < 0.001, respectively). Multivariate logistic regression analysis revealed that low HDL-C is a predictor of CCC (B = 1.456; P < 0.001; odds ratio, 4.3; 95% confidence interval, 1.964-9.369).
CONCLUSION: We found that low HDL-C frequency was more frequent in the poor CCC group than the good CCC group, and HDL-C was a predictor of CCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460232     DOI: 10.2310/JIM.0b013e31824e980c

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  13 in total

1.  Metabolic syndrome and its components reduce coronary collateralization in chronic total occlusion: An observational study.

Authors:  Tong Liu; Zheng Wu; Jinghua Liu; Yun Lv; Wenzheng Li
Journal:  Cardiovasc Diabetol       Date:  2021-05-10       Impact factor: 9.951

2.  Cholesterol Efflux and Collateral Circulation in Chronic Total Coronary Occlusion: Effect-Circ Study.

Authors:  Seonhwa Lee; Jung Mi Park; Soo-Jin Ann; Moonjong Kang; Eun Jeong Cheon; Dan Bi An; Yu Ri Choi; Chan Joo Lee; Jaewon Oh; Sungha Park; Seok-Min Kang; Sang-Hak Lee
Journal:  J Am Heart Assoc       Date:  2021-02-26       Impact factor: 5.501

3.  Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.

Authors:  Ying Shen; Lin Lu; Feng Hua Ding; Zhen Sun; Rui Yan Zhang; Qi Zhang; Zheng Kun Yang; Jian Hu; Qiu Jing Chen; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2013-11-08       Impact factor: 9.951

4.  Predictors of poor coronary collateral development in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets.

Authors:  Fatih Akın; Burak Ayça; Ömer Çelik; Cem Şahin
Journal:  Anatol J Cardiol       Date:  2014-04-08       Impact factor: 1.596

5.  Which Coronary Lesions Are More Prone to Cause Acute Myocardial Infarction?

Authors:  Taner Sen; Mehmet Ali Astarcioglu; Osman Beton; Lale Dinc Asarcikli; Celal Kilit
Journal:  Arq Bras Cardiol       Date:  2017-01-16       Impact factor: 2.000

6.  Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets.

Authors:  Kamil Gülşen; Levent Cerit; Barçın Özcem; Onur Akpınar
Journal:  Anatol J Cardiol       Date:  2015-11       Impact factor: 1.596

Review 7.  Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Feng Hua Ding; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Lin Lu; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-02-08       Impact factor: 9.951

8.  Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Shuai Chen; Yang Dai; Xiao Qun Wang; Rui Yan Zhang; Zhen Kun Yang; Jian Hu; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2019-06-24       Impact factor: 9.951

Review 9.  The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis.

Authors:  Khalia R Primer; Peter J Psaltis; Joanne T M Tan; Christina A Bursill
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

10.  Influence of high-density lipoprotein cholesterol on coronary collateral formation in a population with significant coronary artery disease.

Authors:  Po-Chao Hsu; Ho-Ming Su; Suh-Hang Juo; Hsueh-Wei Yen; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu; Tsung-Hsien Lin
Journal:  BMC Res Notes       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.